Copyright (c) 2020 Sattanathan
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Effectiveness of Clinical Pharmacist Intervention on Smoking Secession
Corresponding Author(s) : Sattanathan
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 2 No. 4 (2014): 2014 Volume 2- Issue -4
Abstract
This work was carried out in a tertiary-care hospital at Calicut,kerala The patients under study will be included, males, children and even females aging between 17 – 75 years with lungs disease, hypertension, coronary artery disease, Asthma, carcinoma and allergic complaints. The study evaluated the effectiveness of a hospital initiated smoking cessation intervention by a clinical pharmacist that included 3 months of follow up and also analyzed the baseline demographics of smokers. The pharmacist-managed Smoking Cessation program successfully aided approximately more than half its participants to quit smoking at 1 and 3 months. Although higher attendance rates increase cessation rates, steps could be taken in order to effectively maximize the pharmacist’s time and minimize patient commitment, while also achieving the best patient outcomes. The most common reasons for quitting smoking were a concern with the current health status and a concern with the future health status.
Keywords
smoking secession
Drug Addiction
Drug Abuse
References
-
[1] Fiore MC, Bailey WC, Cohen SJ. Treating Tobacco Use and Dependence, Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2000.
[2] Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004; 72:1144-56.
[3] Rosen-Chase C, Dyson V. Treatment of nicotine dependence in the chronic mentally ill. J Subst Abuse Treat. 1999; 16:315-20.
[4] Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004; 65:681-91.
[5] Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM. et al., Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004; 44:13-21.
[6] Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE. et al., Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001; 69:471-80.
[7] Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA., et al., The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Pub Med. 2005; 40:249-58.
[8] Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004; 72:371-81.
[9] Rigotti NA, Munafo MR, Murphy MF, Stead LF. Interventions for smoking cessation in hospitalized patients. Cochrane Database systemic Review. 2003; CD001837.
[10] Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004; CD001055.
[11] Lancaster T, Stead LF. Individual behavioralcounselling for smoking cessation. Cochrane Database systemic Review. 2005; CD001292. PubMed.
[12] Dennis Thomaset al., pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomized controlled trial. Thomaset al. Trials 2013; 14: 148-156.
[13] Alan J. Zillich, Pharm.D.,et al.Effectiveness of a Pharmacist-Based Smoking-CessationProgram and Its Impact on Quality of Life. Pharmacotherapy 2002; 22(6):759–765.
[14] Henry HalapyBScPhm, PharmD, Lori MacCallumBScPhm, PharmD . Perspectives in Practice. A Pharmacist-run Smoking Cessation Program, St. Michael’s Hospital,Toronto, Ontario, Canada, 2006;30(4):406-410.
[15] Rouzaud P, Zabotto E, Myon E, TaïebC .Stop Smoking Cessation Target: Observation Program, The French Pharmacist’s Progress. “French Consensus Conference on Smoking Cessation.” 2001; 4(6):501-501.
[16] Mary T. Roth, and Eric C. Westman, M.D., M.H.S.Use of Bupropion SR in a Pharmacist-Managed Outpatient Smoking-Cessation Program. Pharmacotherapy. 2001; 21(5):636–641.
[17] SharonE.Connoret al.,A comparison of homeless and housed patients’ access to and use of pharmacist-provided smoking cessation treatment.Research in Social and Administrative Pharmacy. 2014; 10: 369–377.
[18] Knight CJ et al.,An Evaluation of the Cost-Effectiveness of an Extended Course of varenicline in Preventing Smokers who have quit from Relapsing. The Cochrane Library 2009; 1:1-61.
[19] ThavornK and ChaiyakunaprukN., A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand, Research Gate. 2008; 17(3):177-82.
[20] Zaheer-Ud-din Babar et al., A preliminary study on the effect of pharmacist counseling on awarenessof and willingness to quit smoking in Malaysian population. Pharmacy World and Science. 2007; 29:101-103.
[21] Pamela.R.Fung, R.N.Stellaet al., Effectiveness of Hospital-Based Smoking Cessation. Chest Journal. 2005; 128(1):216-223.
[22] Joel.A.Simon,Timothy.P.Carmodyet al.,Sustained-Release Bupropion for Hospital Based Smoking Cessation.Research gate. 2009; 11(6):663-9.
[23] Karen SuchanekHudmon, Alexander.V.Prokhorovet al.,Tobacco Cessation Counseling, Pharmacists Opinion andPractices. Patient Education and Counselling. 2006 Apr; 61(1):152-160.
References
[1] Fiore MC, Bailey WC, Cohen SJ. Treating Tobacco Use and Dependence, Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2000.
[2] Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004; 72:1144-56.
[3] Rosen-Chase C, Dyson V. Treatment of nicotine dependence in the chronic mentally ill. J Subst Abuse Treat. 1999; 16:315-20.
[4] Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004; 65:681-91.
[5] Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM. et al., Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004; 44:13-21.
[6] Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE. et al., Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001; 69:471-80.
[7] Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA., et al., The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Pub Med. 2005; 40:249-58.
[8] Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004; 72:371-81.
[9] Rigotti NA, Munafo MR, Murphy MF, Stead LF. Interventions for smoking cessation in hospitalized patients. Cochrane Database systemic Review. 2003; CD001837.
[10] Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004; CD001055.
[11] Lancaster T, Stead LF. Individual behavioralcounselling for smoking cessation. Cochrane Database systemic Review. 2005; CD001292. PubMed.
[12] Dennis Thomaset al., pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomized controlled trial. Thomaset al. Trials 2013; 14: 148-156.
[13] Alan J. Zillich, Pharm.D.,et al.Effectiveness of a Pharmacist-Based Smoking-CessationProgram and Its Impact on Quality of Life. Pharmacotherapy 2002; 22(6):759–765.
[14] Henry HalapyBScPhm, PharmD, Lori MacCallumBScPhm, PharmD . Perspectives in Practice. A Pharmacist-run Smoking Cessation Program, St. Michael’s Hospital,Toronto, Ontario, Canada, 2006;30(4):406-410.
[15] Rouzaud P, Zabotto E, Myon E, TaïebC .Stop Smoking Cessation Target: Observation Program, The French Pharmacist’s Progress. “French Consensus Conference on Smoking Cessation.” 2001; 4(6):501-501.
[16] Mary T. Roth, and Eric C. Westman, M.D., M.H.S.Use of Bupropion SR in a Pharmacist-Managed Outpatient Smoking-Cessation Program. Pharmacotherapy. 2001; 21(5):636–641.
[17] SharonE.Connoret al.,A comparison of homeless and housed patients’ access to and use of pharmacist-provided smoking cessation treatment.Research in Social and Administrative Pharmacy. 2014; 10: 369–377.
[18] Knight CJ et al.,An Evaluation of the Cost-Effectiveness of an Extended Course of varenicline in Preventing Smokers who have quit from Relapsing. The Cochrane Library 2009; 1:1-61.
[19] ThavornK and ChaiyakunaprukN., A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand, Research Gate. 2008; 17(3):177-82.
[20] Zaheer-Ud-din Babar et al., A preliminary study on the effect of pharmacist counseling on awarenessof and willingness to quit smoking in Malaysian population. Pharmacy World and Science. 2007; 29:101-103.
[21] Pamela.R.Fung, R.N.Stellaet al., Effectiveness of Hospital-Based Smoking Cessation. Chest Journal. 2005; 128(1):216-223.
[22] Joel.A.Simon,Timothy.P.Carmodyet al.,Sustained-Release Bupropion for Hospital Based Smoking Cessation.Research gate. 2009; 11(6):663-9.
[23] Karen SuchanekHudmon, Alexander.V.Prokhorovet al.,Tobacco Cessation Counseling, Pharmacists Opinion andPractices. Patient Education and Counselling. 2006 Apr; 61(1):152-160.
[2] Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004; 72:1144-56.
[3] Rosen-Chase C, Dyson V. Treatment of nicotine dependence in the chronic mentally ill. J Subst Abuse Treat. 1999; 16:315-20.
[4] Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004; 65:681-91.
[5] Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM. et al., Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004; 44:13-21.
[6] Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE. et al., Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001; 69:471-80.
[7] Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA., et al., The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Pub Med. 2005; 40:249-58.
[8] Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004; 72:371-81.
[9] Rigotti NA, Munafo MR, Murphy MF, Stead LF. Interventions for smoking cessation in hospitalized patients. Cochrane Database systemic Review. 2003; CD001837.
[10] Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004; CD001055.
[11] Lancaster T, Stead LF. Individual behavioralcounselling for smoking cessation. Cochrane Database systemic Review. 2005; CD001292. PubMed.
[12] Dennis Thomaset al., pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomized controlled trial. Thomaset al. Trials 2013; 14: 148-156.
[13] Alan J. Zillich, Pharm.D.,et al.Effectiveness of a Pharmacist-Based Smoking-CessationProgram and Its Impact on Quality of Life. Pharmacotherapy 2002; 22(6):759–765.
[14] Henry HalapyBScPhm, PharmD, Lori MacCallumBScPhm, PharmD . Perspectives in Practice. A Pharmacist-run Smoking Cessation Program, St. Michael’s Hospital,Toronto, Ontario, Canada, 2006;30(4):406-410.
[15] Rouzaud P, Zabotto E, Myon E, TaïebC .Stop Smoking Cessation Target: Observation Program, The French Pharmacist’s Progress. “French Consensus Conference on Smoking Cessation.” 2001; 4(6):501-501.
[16] Mary T. Roth, and Eric C. Westman, M.D., M.H.S.Use of Bupropion SR in a Pharmacist-Managed Outpatient Smoking-Cessation Program. Pharmacotherapy. 2001; 21(5):636–641.
[17] SharonE.Connoret al.,A comparison of homeless and housed patients’ access to and use of pharmacist-provided smoking cessation treatment.Research in Social and Administrative Pharmacy. 2014; 10: 369–377.
[18] Knight CJ et al.,An Evaluation of the Cost-Effectiveness of an Extended Course of varenicline in Preventing Smokers who have quit from Relapsing. The Cochrane Library 2009; 1:1-61.
[19] ThavornK and ChaiyakunaprukN., A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand, Research Gate. 2008; 17(3):177-82.
[20] Zaheer-Ud-din Babar et al., A preliminary study on the effect of pharmacist counseling on awarenessof and willingness to quit smoking in Malaysian population. Pharmacy World and Science. 2007; 29:101-103.
[21] Pamela.R.Fung, R.N.Stellaet al., Effectiveness of Hospital-Based Smoking Cessation. Chest Journal. 2005; 128(1):216-223.
[22] Joel.A.Simon,Timothy.P.Carmodyet al.,Sustained-Release Bupropion for Hospital Based Smoking Cessation.Research gate. 2009; 11(6):663-9.
[23] Karen SuchanekHudmon, Alexander.V.Prokhorovet al.,Tobacco Cessation Counseling, Pharmacists Opinion andPractices. Patient Education and Counselling. 2006 Apr; 61(1):152-160.